These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 8997595)

  • 21. Dysplastic nevi as risk markers of sporadic (nonfamilial) melanoma. A case-control study.
    Halpern AC; Guerry D; Elder DE; Clark WH; Synnestvedt M; Norman S; Ayerle R
    Arch Dermatol; 1991 Jul; 127(7):995-9. PubMed ID: 2064418
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relationship of uveal and cutaneous malignant melanoma in persons with multiple primary tumors.
    Shors AR; Iwamoto S; Doody DR; Weiss NS
    Int J Cancer; 2002 Nov; 102(3):266-8. PubMed ID: 12397648
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risk factors for melanoma incidence in prospective follow-up. The importance of atypical (dysplastic) nevi.
    Schneider JS; Moore DH; Sagebiel RW
    Arch Dermatol; 1994 Aug; 130(8):1002-7. PubMed ID: 8053695
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dysplastic (atypical) nevi: significance and management.
    Lober CW
    South Med J; 1992 Sep; 85(9):870-7. PubMed ID: 1523445
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gene-covariate interaction between dysplastic nevi and the CDKN2A gene in American melanoma-prone families.
    Goldstein AM; Martinez M; Tucker MA; Demenais F
    Cancer Epidemiol Biomarkers Prev; 2000 Sep; 9(9):889-94. PubMed ID: 11008905
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recognition and classification of clinically dysplastic nevi from photographs: a study of interobserver variation.
    Hartge P; Holly EA; Halpern A; Sagebiel R; Guerry D; Elder D; Clark W; Hanson L; Harrison C; Tarone R
    Cancer Epidemiol Biomarkers Prev; 1995; 4(1):37-40. PubMed ID: 7894322
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Common and dysplastic naevi as risk factors for cutaneous malignant melanoma in a Swedish population.
    Augustsson A; Stierner U; Rosdahl I; Suurküla M
    Acta Derm Venereol; 1991; 71(6):518-24. PubMed ID: 1685835
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dysplastic nevus--risk factor or disguise for melanoma.
    Dediol I; Bulat V; Zivković MV; Marković BM; Situm M
    Coll Antropol; 2011 Sep; 35 Suppl 2():311-3. PubMed ID: 22220461
    [TBL] [Abstract][Full Text] [Related]  

  • 29. How common is the atypical mole syndrome phenotype in apparently sporadic melanoma?
    Newton JA; Bataille V; Griffiths K; Squire JM; Sasieni P; Cuzick J; Bishop DT; Swerdlow A
    J Am Acad Dermatol; 1993 Dec; 29(6):989-96. PubMed ID: 8245266
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Atypical mole syndrome: risk factor for cutaneous malignant melanoma and implications for management.
    Slade J; Marghoob AA; Salopek TG; Rigel DS; Kopf AW; Bart RS
    J Am Acad Dermatol; 1995 Mar; 32(3):479-94. PubMed ID: 7868720
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The familial occurrence of cutaneous melanoma, intraocular melanoma, and the dysplastic nevus syndrome.
    Rodriguez-Sains RS
    Am J Ophthalmol; 1984 Jan; 97(1):114-7. PubMed ID: 6696016
    [No Abstract]   [Full Text] [Related]  

  • 32. [The number and distribution of nevus cell nevi in patients with malignant melanoma].
    Welkovich B; Landthaler M; Schmoeckel C; Braun-Falco O
    Hautarzt; 1989 Oct; 40(10):630-5. PubMed ID: 2613517
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Is it necessary to perform eye examination for patients with cutaneous atypical nevi?
    Karaarslan I; Yagcı A; Acar A; Sahin A; Ozkapu T; Palamar M; Ozdemir F
    Dermatol Ther; 2020 Nov; 33(6):e14503. PubMed ID: 33142003
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dysplastic nevi and other risk markers for melanoma.
    Seykora J; Elder D
    Semin Oncol; 1996 Dec; 23(6):682-7. PubMed ID: 8970587
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genetic study of familial uveal melanoma: association of uveal and cutaneous melanoma with cutaneous and ocular nevi.
    Smith JH; Padnick-Silver L; Newlin A; Rhodes K; Rubinstein WS
    Ophthalmology; 2007 Apr; 114(4):774-9. PubMed ID: 17207529
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biopsy diagnoses of clinically atypical pigmented lesions of the head and neck in adults.
    Udovenko O; Griffin JR; Elston DM
    Am J Dermatopathol; 2014 Oct; 36(10):829-31. PubMed ID: 25247672
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Frequency of dysplastic nevi among nevomelanocytic lesions submitted for histopathologic examination. Time trends over a 37-year period.
    Barnhill RL; Kiryu H; Sober AJ; Mihm MC
    Arch Dermatol; 1990 Apr; 126(4):463-5. PubMed ID: 2321991
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dysplastic vulvar nevi.
    Blickstein I; Feldberg E; Dgani R; Ben-Hur H; Czernobilsky B
    Obstet Gynecol; 1991 Nov; 78(5 Pt 2):968-70. PubMed ID: 1923241
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dysplastic nevi, cutaneous melanoma, and gynecologic disorders.
    Frisch RE; Wyshak G; Albert LS; Sober AJ
    Int J Dermatol; 1992 May; 31(5):331-5. PubMed ID: 1587661
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dysplastic nevus (atypical nevus).
    Rezze GG; Leon A; Duprat J
    An Bras Dermatol; 2010; 85(6):863-71. PubMed ID: 21308311
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.